ストックスクリーナーアプリを入手
1.86
5.08%
0.09
前日終値:
$1.77
開ける：
$1.79
24時間の取引高:
1.29M
Relative Volume:
0.49
時価総額：
$203.02M
収益：
$100.56M
当期純損益:
$-119.05M
株価収益率:
-1.5122
EPS:
-1.23
ネットキャッシュフロー:
$-231.16M
1週間 パフォーマンス:
+21.57%
1か月 パフォーマンス:
+45.31%
6か月 パフォーマンス:
+12.73%
1年 パフォーマンス:
-1.06%
1日の値動き範囲:
$1.76
$1.87
1週間の範囲:
$1.51
$1.87
52週間の値動き範囲:
$0.87
$3.3999
Alector Inc Stock (ALEC) Company Profile
名前
Alector Inc
セクター
電話
415-231-5660
住所
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
ALEC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.86 | 193.20M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-22 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-10-22 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-22 | ダウングレード | Mizuho | Outperform → Neutral |
| 2025-10-22 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-10-22 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-07-28 | アップグレード | Mizuho | Neutral → Outperform |
| 2024-12-17 | ダウングレード | Mizuho | Outperform → Neutral |
| 2024-12-16 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-04 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-11-29 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-11-26 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | アップグレード | Stifel | Hold → Buy |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2023-09-25 | 開始されました | Goldman | Sell |
| 2023-09-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-01-06 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-09-09 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-13 | 開始されました | Goldman | Sell |
| 2022-03-08 | ダウングレード | Stifel | Buy → Hold |
| 2021-09-27 | 開始されました | William Blair | Outperform |
| 2021-01-15 | 再開されました | BofA Securities | Buy |
| 2020-06-24 | 開始されました | H.C. Wainwright | Buy |
| 2020-04-28 | 開始されました | Goldman | Buy |
| 2020-03-06 | 開始されました | Citigroup | Buy |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2020-02-19 | 開始されました | Stifel | Buy |
| 2019-11-21 | 開始されました | BTIG Research | Buy |
| 2019-03-04 | 開始されました | Barclays | Overweight |
| 2019-03-04 | 開始されました | BofA/Merrill | Buy |
| 2019-03-04 | 開始されました | Morgan Stanley | Overweight |
| 2019-03-04 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Alector Inc (ALEC) 最新ニュース
How rising interest rates impact Alector Inc. stock2025 EndofYear Setup & Growth Focused Investment Plans - ulpravda.ru
How institutional buying supports Alector Inc. stockInflation Watch & Stepwise Entry/Exit Trade Alerts - ulpravda.ru
What insider trading reveals about Alector Inc. stockRetail Investor Activity & Low Cost Stock Ideas - bollywoodhelpline.com
Will Alector Inc. (0Z2) stock profit from automation waveMarket Volume Summary & Technical Buy Zone Confirmation - ulpravda.ru
Guidance Update: How institutional buying supports Alector Inc. stockJuly 2025 Review & Free High Return Stock Watch Alerts - ulpravda.ru
Will Alector Inc. stock split again soonWeekly Trade Recap & AI Optimized Trading Strategy Guides - ulpravda.ru
Levi & Korsinsky Announces an Investigation on Behalf of Alector, Inc. (ALEC) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Alector : January 2026 Corporate Presentation - MarketScreener
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Alector, Inc. (ALEC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Setup Watch: Will Sound Group Inc Depositary Receipt stock see PE expansion2025 Technical Patterns & Smart Allocation Stock Tips - moha.gov.vn
ALEC ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Alector, Inc. - ACCESS Newswire
Alector, Inc. (NASDAQ:ALEC) Given Average Rating of "Reduce" by Analysts - MarketBeat
Investors who lost money on Alector, Inc. should contact Levi & Korsinsky about an ongoing investigationALEC - ACCESS Newswire
Short Interest in Alector, Inc. (NASDAQ:ALEC) Expands By 35.9% - MarketBeat
Alector (NASDAQ:ALEC) Trading 4.8% HigherHere's Why - MarketBeat
Alector, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsALEC - ACCESS Newswire
Shareholder Rights Advocates at Levi & Korsinsky Investigate Alector, Inc. (ALEC) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Is Alector Inc a good long term investmentInterest Rate Changes & Affordable Trading Techniques - earlytimes.in
Alector, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsALEC - ACCESS Newswire
Is Alector Inc. stock attractive for hedge fundsJuly 2025 Big Picture & AI Optimized Trading Strategy Guides - Улправда
What catalysts could drive Alector Inc. stock higherMarket Growth Review & AI Powered Trade Plan Recommendations - Улправда
Profit Review: How rising interest rates impact Alector Inc. stockShort Setup & Reliable Volume Spike Trade Alerts - Улправда
Alector appoints Neil Berkley as chief financial officer - MSN
Hedge Fund Bets: Can Alector Inc. stock sustain free cash flow growth2025 Stock Rankings & Reliable Entry Point Trade Alerts - Улправда
Will Alector Inc. stock outperform tech sector in 2025CEO Change & Daily Technical Forecast Reports - Улправда
Shareholders that lost money on Alector, Inc.(ALEC) should contact Levi & Korsinsky about Securities Fraud InvestigationALEC - ACCESS Newswire
Will Alector Inc. stock reach Wall Street targetsPortfolio Performance Report & High Conviction Buy Zone Alerts - DonanımHaber
Can Alector Inc. (0Z2) stock deliver strong annual returnsJuly 2025 Drop Watch & Smart Allocation Stock Tips - DonanımHaber
Is Alector Inc. stock a top momentum play2025 Bull vs Bear & Daily Technical Stock Forecast Reports - DonanımHaber
Options Flow: What catalysts could drive Alector Inc. stock higherJuly 2025 Summary & Expert-Curated Trade Recommendations - Улправда
Will Alector Inc. stock reach all time highs in 2025Bond Market & Fast Moving Stock Trade Plans - DonanımHaber
Can Alector Inc. stock sustain free cash flow growthFed Meeting & Free Weekly Watchlist of Top Performers - Улправда
Will Alector Inc. stock deliver long term returnsJuly 2025 Technicals & Low Risk Growth Stock Ideas - Улправда
Alector, Inc.(NasdaqGS: ALEC) dropped from NASDAQ Biotechnology Index - marketscreener.com
Investigation Alert: Alector, Inc. (ALEC) Under ScrutinyContact Levi & Korsinsky For Details - ACCESS Newswire
Alector Earnings Notes - Trefis
Alector Stock Down After Latozinemab Failure, Eyes On Phase 2 Catalyst (ALEC) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Alector (ALEC) and Novan (NOVN) - The Globe and Mail
Alector (ALEC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Alector Appoints Neil Berkley as CFO - The Globe and Mail
How currency fluctuations impact Alector Inc stockMarket Trend Report & Expert Approved Momentum Trade Ideas - moha.gov.vn
Rate Cut: Is Alector Inc stock a safe investment in uncertain marketsTrade Entry Summary & Smart Swing Trading Techniques - moha.gov.vn
Alector (ALEC) Appoints Neil Berkley as CFO - GuruFocus
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer - The Manila Times
Alector, Inc. Appoints Neil Berkley as Chief Financial Officer - Quiver Quantitative
Alector (NASDAQ: ALEC) appoints Neil Berkley as chief financial officer - Stock Titan
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer | Associated Press | syndication news - Enidnews.com
Alector, Inc. Appoints Neil Berkley as Chief Financial Officer, Effective December 10, 2025 - marketscreener.com
Alector Announces Topline Results from Phase 3 INFRONT-3 Clinical Trial Evaluating Latozinemab - MSN
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment - MSN
Alector Inc (ALEC) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
大文字化:
|
ボリューム (24 時間):